Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 22;22(35):12406-14.
doi: 10.1002/chem.201601754. Epub 2016 Jul 27.

Cellular Cations Control Conformational Switching of Inositol Pyrophosphate Analogues

Anastasia Hager  1 , Mingxuan Wu  1 , Huanchen Wang  2 , Nathaniel W Brown Jr  3   1 , Stephen B Shears  2 , Nicolás Veiga  4 , Dorothea Fiedler  5   6
Affiliations

Cellular Cations Control Conformational Switching of Inositol Pyrophosphate Analogues

Anastasia Hager et al. Chemistry. .

Abstract

The inositol pyrophosphate messengers (PP-InsPs) are emerging as an important class of cellular regulators. These molecules have been linked to numerous biological processes, including insulin secretion and cancer cell migration, but how they trigger such a wide range of cellular responses has remained unanswered in many cases. Here, we show that the PP-InsPs exhibit complex speciation behaviour and propose that a unique conformational switching mechanism could contribute to their multifunctional effects. We synthesised non-hydrolysable bisphosphonate analogues and crystallised the analogues in complex with mammalian PPIP5K2 kinase. Subsequently, the bisphosphonate analogues were used to investigate the protonation sequence, metal-coordination properties, and conformation in solution. Remarkably, the presence of potassium and magnesium ions enabled the analogues to adopt two different conformations near physiological pH. Understanding how the intrinsic chemical properties of the PP-InsPs can contribute to their complex signalling outputs will be essential to elucidate their regulatory functions.

Keywords: biological activity; conformation analysis; phosphorylation; protonation; signal transduction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Inositol pyrophosphates and their corresponding bisphosphonate analogues. a) Abbreviated biosynthetic pathway to generate the messengers 5-diphosphoinositol pentakisphosphate (5PP-InsP5), and 1,5-bis(diphosphoinositol) tetrakisphosphate (1,5(PP)2-InsP4). b) Bisphosphonate analogues reported here, and their applications.
Figure 2
Figure 2
Structural analysis of bisphosphonate analogues in complex with PPIP5K2. a) Electrostatic surface presentation of the active site of PPIP5K2 with 5PCP-InsP5 bound. b) Superimposition of the catalytic domains of PPIP5K2 bound to 5PCP-InsP5 (cyan C–C bonds) or 5PP-InsP5 (grey C–C bonds and white spheres for all atoms). c) Superimposition of the carbon atoms of the inositol ring in 5PCP-InsP5 (cyan C–C bonds) or 5PP-InsP5 (grey C–C bonds and white spheres for all atoms). d) Electrostatic surface presentation of the active site of PPIP5K2 with 3,5(PCP)2-InsP4 bound. e) Superimposition of the catalytic domains of PPIP5K2 bound to 3,5(PCP)2-InsP4 (yellow C–C bonds) or 3,5(PP)2-InsP4 (white C–C bonds and white spheres for all atoms). f) Superimposition of the carbon atoms of the inositol ring in 3,5(PCP)2-InsP4 (yellow C–C bonds) or 3,5(PP)2-InsP4 (white C–C bonds and white spheres for all atoms).
Figure 3
Figure 3
NMR titration of 5PCP-InsP5 (1) without coordinating counter ions. a) and b) 31P NMR chemical shifts of 1 as a function of pH, measured in 0.15M NMe4Cl at 22.0 °C. Solid lines indicate the chemical shifts predicted by HypNMR, according to the protonation constants given in Table S1. c) Corresponding species distribution diagram of 1. Predictions are for [L]=1.0 mM. The pH range of the ligand conformational change is highlighted in grey.
Figure 4
Figure 4
pH-Dependent conformational change of 5PCP-InsP5 (1). a) Schematic illustrating the transition from the 1a5e (1 axial, 5 equatorial) to 5a1e (5 axial, 1 equatorial) conformation at elevated pH. b)–d) DFT optimised geometries for the most stable conformers of L13− (b), HL12− (c), and H2L11− (d). The intramolecular hydrogen bonds are shown as black dotted lines. Phosphoryl groups forming intramolecular hydrogen bonds are in bold. Colour code: C (grey), H (white), O (red), P (orange).
Figure 5
Figure 5
Species distribution diagrams of 5PCP-InsP5 (1) in the presence of potassium and magnesium ions. a) [1] =1.0 mm, [K+]=150 mM. b) [1] =1.0 mM, [K+]=150 mm, [Mg2+]=1.0 mm. T =22.08C. The pH range of the ligand conformational change is highlighted in grey.
Figure 6
Figure 6
DFT optimised geometries for the detected 5PCP-InsP5 species in complex with potassium and magnesium ions. Intramolecular hydrogen bonds are shown as black dotted lines. Two unique hydrogen bonds from P5β to a water molecule in the first coordination sphere of magnesium are highlighted as green dotted lines. Phosphoryl groups forming intramolecular hydrogen bonds are in bold. Colour code: C (grey), H (white), O (red), P (orange), K (violet), Mg (lime green).
Figure 7
Figure 7
Effect of magnesium ions on the conformational equilibrium of InsP6, 5PCP-InsP5 (1) and rac-(PCP)2-InsP4 (rac-2). Schematic illustrating a shift of the conformational change of InsP6, 1 and rac-2, towards physiological pD upon addition of magnesium.
Scheme 1
Scheme 1
Synthesis of 5PCP-InsP5 (1).
Scheme 2
Scheme 2
Synthesis of 1,5-(PCP)2-InsP4 and 3,5-(PCP)2-InsP4.
See this image and copyright information in PMC

References

    1. Irvine RF, Schell MJ. Nat Rev Mol Cell Biol. 2001;2:327–338. - PubMed
    2. Irvine RF. J Physiol. 2005;566:295–300. - PMC - PubMed
    1. Shears SB. Adv Biol Regul. 2015;57:203–216. - PMC - PubMed
    2. Wilson MS, Livermore TM, Saiardi A. Biochem J. 2013;452:369–379. - PubMed
    3. Wundenberg T, Mayr GW. Biol Chem. 2012;393:979–998. - PubMed
    4. Chakraborty A, Kim S, Snyder SH. Science Signal. 2011;4:re1–11. - PMC - PubMed
    5. Barker CJ, Illies C, Gaboardi GC, Berggren PO. Cell Mol Life Sci. 2009;66:3851–3871. - PMC - PubMed
    6. Monserrate JP, York JD. Curr Opin Cell Biol. 2010;22:365–373. - PubMed
    1. Stephens L, Radenberg T, Thiel U, Vogel G, Khoo KH, Dell A, Jackson TR, Hawkins PT, Mayr GW. J Biol Chem. 1993;268:4009–4015. - PubMed
    2. Menniti FS, Miller RN, Putney JW, Shears SB. J Biol Chem. 1993;268:3850–3856. - PubMed
    3. Glennon MC, Shears SB. Biochem J. 1993;293:583–590. - PMC - PubMed
    1. Saiardi A, Erdjument-Bromage H, Snowman AM, Tempst P, Snyder SH. Curr Biol. 1999;9:1323–1326. - PubMed
    2. Saiardi A, Nagata E, Luo HR, Snowman AM, Snyder SH. J Biol Chem. 2001;276:39179–39185. - PubMed
    3. Schell MJ, Letcher AJ, Brearley CA, Biber J, Murer H, Irvine RF. FEBS Lett. 1999;461:169–172. - PubMed
    4. Voglmaier SM, Bembenek ME, Kaplin AI, Dorman G, Olszewski JD, Prestwich GD, Snyder SH. Proc Natl Acad Sci USA. 1996;93:4305–4310. - PMC - PubMed
    1. Mulugu S, Bai W, Fridy PC, Bastidas RJ, Otto JC, Dollins DE, Haystead TA, Ribeiro AA, York JD. Science. 2007;316:106–109. - PubMed
    2. Choi JH, Williams J, Cho J, Falck JR, Shears SB. J Biol Chem. 2007;282:30763–30775. - PMC - PubMed
    3. Lin H, Fridy PC, Ribeiro AA, Choi JH, Barma DK, Vogel G, Falck JR, Shears SB, York JD, Mayr GW. J Biol Chem. 2008;284:1863–1872. - PMC - PubMed

LinkOut - more resources